Page last updated: 2024-08-24

pazufloxacin and Bacterial Disease

pazufloxacin has been researched along with Bacterial Disease in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (71.43)18.2507
2000's2 (28.57)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hattori, R; Matsuda, A; Minami, S1
Fukuoka, Y; Ikeda, Y; Narita, H; Takahata, M; Todo, Y; Yamashiro, Y1
Kimura, H; Miyake, H; Sakai, M; Shinkawa, A1
Kobayashi, H1
Fukuyama, M; Hara, M; Imagawa, Y; Oonaka, K1
Ajisawa, A; Bamba, T; Fukuda, H; Hosoda, S; Imai, T; Irimajiri, S; Katoh, K; Masuda, G; Matsumoto, F; Mizuno, Y; Mori, M; Murata, M; Negishi, M; Nitta, Y; Obana, M; Ohnishi, K; Sagara, H; Saito, M; Sakurai, I; Takahashi, T; Takizawa, Y; Tomizawa, I; Tsunoda, T; Yamaguchi, T; Yoshikawa, K1
Johnson, AP1

Reviews

2 review(s) available for pazufloxacin and Bacterial Disease

ArticleYear
[Pharmacological properties and expected clinical role of an injectable new quinolone antibiotic, pazufloxacin mesilate].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2003, Volume: 122, Issue:2

    Topics: 4-Quinolones; Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Capillary Permeability; DNA Gyrase; DNA Replication; DNA, Bacterial; Drug Resistance, Bacterial; Fluoroquinolones; Hemodynamics; Histamine Release; Humans; Infusions, Intravenous; Oxazines; Seizures

2003
Pazufloxacin Toyama Chemical Co.
    Current opinion in investigational drugs (London, England : 2000), 2000, Volume: 1, Issue:1

    Topics: Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Clinical Trials as Topic; Drugs, Investigational; Fluoroquinolones; Humans; Oxazines; Structure-Activity Relationship

2000

Trials

2 trial(s) available for pazufloxacin and Bacterial Disease

ArticleYear
Pharmacokinetic and clinical studies of T-3761 in otorhinolaryngeal infections.
    Drugs, 1995, Volume: 49 Suppl 2

    Topics: Anti-Infective Agents; Bacteria; Bacterial Infections; Chromatography, High Pressure Liquid; Fluoroquinolones; Humans; Otorhinolaryngologic Diseases; Oxazines

1995
Interim results from a multicentre clinical trial of T-3761 in Japan.
    Drugs, 1995, Volume: 49 Suppl 2

    Topics: Anti-Infective Agents; Bacterial Infections; Dose-Response Relationship, Drug; Fluoroquinolones; Humans; Japan; Oxazines

1995

Other Studies

3 other study(ies) available for pazufloxacin and Bacterial Disease

ArticleYear
In vitro and in vivo antibacterial activities of T-3761, a new quinolone derivative.
    Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:3

    Topics: Animals; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Fluoroquinolones; Lung Diseases; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Urinary Tract Infections

1993
[In vitro antibacterial activity of pazufloxacin (PZFX) against clinical isolates from infectious enteritis].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 1996, Volume: 70, Issue:1

    Topics: 4-Quinolones; Anti-Infective Agents; Bacteria; Bacterial Infections; Drug Resistance, Microbial; Enteritis; Fluoroquinolones; Humans; Oxazines

1996
[Basic and clinical studies of pazufloxacin on infectious enteritis research group of T-3761 on infectious enteritis].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 1996, Volume: 70, Issue:1

    Topics: 4-Quinolones; Anti-Infective Agents; Bacterial Infections; Carrier State; Cholera; Drug Resistance, Microbial; Dysentery, Bacillary; Enteritis; Escherichia coli Infections; Fluoroquinolones; Humans; Oxazines; Salmonella Infections

1996